VERACYTE, INC. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2020 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Veracyte, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q1 2023.
- Veracyte, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Veracyte, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$3.92M.
- Veracyte, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$427K.
- Veracyte, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$6.2M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)